ホーム > 小原直/ Obara, Naoshi

小原直

Obara, Naoshi

血液内科 , 教授
Faculty of Medicine

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

21. Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine. Shinichi Ogawa; Tatsuhiro Sakamoto; Ryota Matsuoka; Kantaro Ishitsuka (+14 著者) Shigeru Chiba
Cancer reports (Hoboken, N.J.) 7: e1938 (2024) Semantic Scholar
22. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation]. Haruka Momose; Naoki Kurita; Hidekazu Nishikii; Nozomi Yusa (+11 著者) Shigeru Chiba
[Rinsho ketsueki] The Japanese journal of clinical hematology 65: 35 (2024) Semantic Scholar
23. Repeated immunosuppressive rabbit antithymocyte globulin therapy for adult patients with relapsed or refractory aplastic anemia. Tatsuhiro Sakamoto; Naoshi Obara; Yumiko Maruyama; Takayasu Kato (+7 著者) Shigeru Chiba
European journal of haematology 111: 768 (2023) Semantic Scholar
24. A longitudinal analysis of paroxysmal nocturnal haemoglobinuria-type cells in patients with bone marrow failure: Results of a prospective multi-centre study in Japan. Ken Ishiyama; Yuji Yonemura; Tatsuya Kawaguchi; Kohei Hosokawa (+12 著者) Shinji Nakao
British journal of haematology 203: 468 (2023) Semantic Scholar
25. 発作性夜間ヘモグロビン尿症患者におけるラブリズマブ高濃度製剤の安全性、有効性に関する検討西脇嘉一; 臼杵憲祐; 池添隆之; 石山謙 (+6 著者) 西村純一
日本血液学会学術集会 85回: 576 (2023)
26. Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial. Naoki Kurita; Hidekazu Nishikii; Yumiko Maruyama; Yasuhito Suehara (+13 著者) Shigeru Chiba
Annals of hematology 102: 2895 (2023) Semantic Scholar
27. Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan. Kensuke Usuki; Takayuki Ikezoe; Ken Ishiyama; Yoshinobu Kanda (+5 著者) Jun-Ichi Nishimura
International journal of hematology 118: 311 (2023) Semantic Scholar
28. Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial. Alexander Röth; Satoshi Ichikawa; Yoshikazu Ito; Jin Seok Kim (+14 著者) Jun-Ichi Nishimura
European journal of haematology 111: 300 (2023) Semantic Scholar
29. Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations Yuri Tsuboi; Tatsuhiro Sakamoto; Kenichi Makishima; Yasuhito Suehara (+9 著者) Mamiko Sakata-Yanagimoto
Internal medicine (Tokyo, Japan) 62: 1527 (2023) Semantic Scholar
30. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia. Yoshinobu Kanda; Kensuke Usuki; Mitsuhiro Inagaki; Akiko Ohta (+9 著者) Hirohito Yamazaki
International journal of hematology 117: 660 (2023) Semantic Scholar
31. The fatty acid elongase Elovl6 is crucial for hematopoietic stem cell engraftment and leukemia propagation. Yusuke Kiyoki; Takayasu Kato; Sakura Kito; Takashi Matsuzaka (+9 著者) Shigeru Chiba
Leukemia 37: 910 (2023) Semantic Scholar
32. Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion Yuri Tsuboi; Yumoe Iimura; Fumiaki Matsumura; Toru Nanmoku (+16 著者) Mamiko Sakata-Yanagimoto
Internal medicine (Tokyo, Japan) 62: 595 (2023) Semantic Scholar
33. [Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis]. Ayako Takarada; Haruka Momose; Naoki Kurita; Ryota Matsuoka (+10 著者) Mamiko Sakata-Yanagimoto
[Rinsho ketsueki] The Japanese journal of clinical hematology 64: 54 (2023) Semantic Scholar
34. 免疫抑制療法後にASXL1変異クローンで造血が回復した重症再生不良性貧血清水百萌; 錦井秀和; 飯塚正; 松岡亮太 (+12 著者) 小原直
[Rinsho ketsueki] The Japanese journal of clinical hematology 64: 49 (2023) Semantic Scholar
35. 神経浸潤による末梢神経障害を合併した原発性マクログロブリン血症法岡菜月; 栗田尚樹; 加村雄哉; 坂本竜弘 (+12 著者) 千葉滋
[Rinsho ketsueki] The Japanese journal of clinical hematology 64: 18 (2023) Semantic Scholar
36. Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation. Kantaro Ishitsuka; Yuki Yoshizawa; Hidekazu Nishikii; Manabu Kusakabe (+11 著者) Shigeru Chiba
Leukemia & lymphoma 63: 3475 (2022) Semantic Scholar
37. Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution. Akira Matsuda; Kazunori Imada; Naoshi Obara; Hiroatsu Iida (+11 著者) Shinji Nakao
American journal of clinical pathology 158: 604 (2022) Semantic Scholar
38. Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events. Kantaro Ishitsuka; Yasuhisa Yokoyama; Naoko Baba; Ryota Matsuoka (+9 著者) Shigeru Chiba
Journal of clinical and experimental hematopathology : JCEH 62: 154 (2022) Semantic Scholar
39. Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria Yuya Kamura; Tatsuhiro Sakamoto; Yasuhisa Yokoyama; Hidekazu Nishikii (+2 著者) Naoshi Obara
International journal of hematology 116: 55 (2022) Semantic Scholar
40. Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure. Sakurako Suma; Yasuhisa Yokoyama; Haruka Momose; Kenichi Makishima (+9 著者) Shigeru Chiba
Internal medicine (Tokyo, Japan) 61: 1673 (2022) Semantic Scholar

« 1 2 3 4 … 8 »

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

知財情報はまだありません。

359 total views

この研究者の他の情報源

キーワードが似ている研究者

坂田（柳元）麻実子骨髄異形成症候群, lymphoma
小島寛 ALUMNI 造血幹細胞
菅谷久 ALUMNI 造血幹細胞
全孝静 ALUMNI 造血幹細胞
大川敬子造血幹細胞

この研究者の他の情報源

キーワードが似ている研究者

この研究者の情報を共有